Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Bajaj Finserv Healthcare Fund Direct Growth
NAV: 09 Oct '26
₹11.55
Min. for SIP
₹500
Fund size (AUM)
₹405.14 Cr
Expense ratio
0.90%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,521 | -3.19% | |
| 6 months | ₹30,000 | ₹30,596 | +1.99% | |
| 1 year | ₹60,000 | ₹65,961 | +9.93% |
Holdings (36)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | Equity | 9.75% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.96% |
| Piramal Pharma Ltd | Healthcare | Equity | 6.36% |
| Rubicon Research Ltd. | Healthcare | Equity | 6.08% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 6.03% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.51% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.78% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 4.03% |
| Laurus Labs Ltd | Healthcare | Equity | 3.91% |
| Neuland Laboratories Ltd | Healthcare | Equity | 3.82% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 2.99% |
| Alkem Laboratories Ltd | Healthcare | Equity | 2.96% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.57% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.40% |
| Others CBLO | Unspecified | CBLO | 2.32% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.28% |
| Zydus Wellness Ltd | Consumer Staples | Equity | 2.20% |
| Vijaya Diagnostic Centre Ltd | Healthcare | Equity | 2.19% |
| Senores Pharmaceuticals Ltd. | Healthcare | Equity | 2.08% |
| Shaily Engineering Plastics Ltd | Materials | Equity | 1.88% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 1.73% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 1.63% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 1.60% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 1.37% |
| Cipla Ltd | Healthcare | Equity | 1.33% |
| Bajaj Finserv Money Market Fund Direct-Growth | Unspecified | Mutual Fund | 1.31% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | Equity | 1.30% |
| Biocon Ltd | Healthcare | Equity | 1.05% |
| Navin Fluorine International Ltd | Materials | Equity | 0.94% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 0.92% |
| Jubilant Pharmova Ltd | Healthcare | Equity | 0.89% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 0.83% |
| Net Receivables | Unspecified | Net Receivables | 0.81% |
| Medi Assist Healthcare Services Ltd. | Industrials | Equity | 0.75% |
| Neogen Chemicals Ltd | Materials | Equity | 0.23% |
| Sumitomo Chemical India Ltd | Materials | Equity | 0.21% |
See All
Minimum investments
Min. for 1st investment
₹500
Min. for 2nd investment
₹100
Min. for SIP
₹500
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +2.3% | +21.3% | +16.9% | +15.5% |
| Category average (Equity Sectoral) | -1.0% | +15.9% | +13.7% | +176.8% |
| Rank (Equity Sectoral) | 2 | 3 | 6 | -- |
Exit load, stamp duty and tax
Exit load
1% for redemption within 3 Months
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
SCSiddharth ChaudharyDec 2024 - PresentView details
SC
Siddharth Chaudhary
Dec 2024 - Present
View details
SGSorbh GuptaSep 2026 - PresentView details
SG
Sorbh Gupta
Sep 2026 - Present
View details
BHBharat HegdeMay 2026 - PresentView details
BH
Bharat Hegde
May 2026 - Present
View details
About Bajaj Finserv Healthcare Fund Direct Growth
Bajaj Finserv Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Bajaj Finserv Mutual Fund. This scheme was made available to investors on 18 Oct 2021. Siddharth Chaudhary is the Current Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹40,430 Cr and the Latest NAV as of 09 Oct 2026 is ₹11.55.
The Bajaj Finserv Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹500. Minimum Lumpsum Investment is ₹500. 1% for redemption within 3 Months
;
Investment Objective
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)--
Total AUM₹40,430.09 Cr
Date of Incorporation18 Oct 2021
Launch Date18 Oct 2021
AddressS. No - 239/2, 11th Floor, Office No. 1101 A and 1101 B,Sky One Corporate Park, Lohegaon, Pune, Maharashtra Pune 411032
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,